Spraarsh Therapeutics Private Limited
About Spraarsh Therapeutics Private Limited
Data last updated:
Spraarsh Therapeutics Private Limited is a private limited company based in Changsari, Assam, India. It operates in the social science research segment of the research and development sector. It was incorporated on 12 December 2022.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U73200AS2022PTC023968.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pemmaraju Venkata Pavan Deepak Bharadwaj and Manjeera Palagummi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Roomno.L4 Bionest Niper Guwahati Incubation Centre Niper – G Silakatamur, Changsari, Assam, India – 781101.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRoomno.L4 Bionest Niper Guwahati Incubation Centre Niper – G Silakatamur, Changsari, Assam, India – 781101
- IndustryResearch & Development, Social Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Board of Directors of Spraarsh Therapeutics Private Limited
Spraarsh Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pemmaraju Venkata Pavan Deepak Bharadwaj | Director | 12 Dec 2022 | 3 Years 9 Months | Current |
| Manjeera Palagummi | Director | 12 Dec 2022 | 3 Years 9 Months | Current |
Financials of Spraarsh Therapeutics Private Limited FY 2025 filings available
Financial Statement Summary of Spraarsh Therapeutics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Spraarsh Therapeutics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Spraarsh Therapeutics are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Spraarsh Therapeutics Private Limited
Spraarsh Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Spraarsh Therapeutics Private Limited
Employment history and EPFO contributions of people linked to Spraarsh Therapeutics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Spraarsh Therapeutics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Spraarsh Therapeutics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Spraarsh Therapeutics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Spraarsh Therapeutics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Spraarsh Therapeutics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Spraarsh Therapeutics Private Limited
Frequently Asked Questions about Spraarsh Therapeutics Private Limited
Spraarsh Therapeutics is an active private limited company based in Changsari, Assam, India. The company works in social science research, within the research and development industry. It was incorporated on 12 December 2022 (4+ years old) and is registered under CIN U73200AS2022PTC023968.
Spraarsh Therapeutics has 2 current directors:
- Pemmaraju Venkata Pavan Deepak Bharadwaj - Director
- Manjeera Palagummi - Director
The CIN (Corporate Identification Number) of Spraarsh Therapeutics is U73200AS2022PTC023968. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spraarsh Therapeutics was incorporated on 12 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Guwahati.
The registered office of Spraarsh Therapeutics is at Roomno.L4 Bionest Niper Guwahati Incubation Centre Niper – G Silakatamur, Changsari, Assam, India – 781101.
Spraarsh Therapeutics has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh.
Spraarsh Therapeutics operates in the research and development industry, in the social science research segment.
No. Spraarsh Therapeutics is not listed on any stock exchange. It is an unlisted company.
The compliance status of Spraarsh Therapeutics is compliant as of 13 August 2026. The company is actively filing with the Registrar of Companies.